The Trump administration has continued to tighten sanctions on Iran since it announced the U.S. withdrawal from the Joint Comprehensive Plan of Action in May 2018.
The latest actions, including the designation of the Central Bank of Iran, may further complicate business transactions authorized under existing licensing regimes. At the same time, a new process may allow foreign governments and financial institutions to obtain safe harbor from U.S. sanctions for humanitarian trade in exchange for regular reports of "robust" information, providing possible opportunities for those wishing to trade with Iran while enhancing the U.S. government's access to information from foreign parties.
In this installment of the Trade Demystified video series, Adam Berry discusses recent Iran developments as well as the impact on humanitarian trade and the general licenses authorizing trade in food, medicine, and medical devices.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.